Acadia Pharmaceuticals reported $542.22M in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 542.22M 75.6M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Aptinyx Inc APTX:US $ 106.53M 8.22M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Cara Therapeutics CARA:US $ 151.76M 21.53M
Corcept Therapeutics CORT:US $ 388.22M 121.76M
Cytokinetics CYTK:US $ 623.53M 87.85M
Eisai 4523:JP Y 640606M 53549M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
Intra Cellular Therapies ITCI:US $ 848.34M 381.06M
Marinus Pharmaceuticals MRNS:US $ 135.07M 3.39M
Moderna Inc MRNA:US 16.35B 279M
Prothena PRTA:US 555.62M 29.19M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Seattle Genetics SGEN:US $ 2771.26M 97.94M
Ultragenyx Pharmaceutical RARE:US $ 707.52M 149.08M
Vanda Pharmaceuticals VNDA:US $ 492.27M 13.97M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
YTE INCY:US $ 3288.09M 169.42M